Showing results (141-150 of 168) with videos related to

Sort By:
Pageof 17
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 12, 2020
Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for T Cell Acute Lymphoblastic Leukemia: A Report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working PartyAli Bazarbachi, Myriam Labopin, Emanuele Angelucci, et al.
Blood Advances|August 20, 2020
Impact of donor age and kinship on clinical outcomes after T-cell-replete haploidentical transplantation with PT-CyJacopo Mariotti, Anna Maria Raiola, Andrea Evangelista, et al.
Hemasphere|February 27, 2023
Prediction of Nonrelapse Mortality in Patients With Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia Receiving Allogeneic Stem Cell Transplantation With Posttransplantation Cyclophosphamide-based Graft Versus Host Disease ProphylaxisSjoerd J F Hermans, Jurjen Versluis, Myriam Labopin, et al.
Blood Cancer Discovery|July 2, 2024
A Multicenter Real-life Prospective Study of Axicabtagene Ciloleucel versus Tisagenlecleucel Toxicity and Outcomes in Large B-cell LymphomasFederico Stella, Annalisa Chiappella, Beatrice Casadei, et al.
Bone Marrow Transplantation|September 3, 2022
Impact of second-degree related donor on the outcomes of T cell-replete haploidentical transplantation with post-transplant cyclophosphamideJacopo Mariotti, Anna Maria Raiola, Andrea Evangelista, et al.
The Lancet. Haematology|September 23, 2024
Venetoclax plus decitabine as a bridge to allogeneic haematopoietic stem-cell transplantation in older patients with acute myeloid leukaemia (VEN-DEC GITMO): final report of a multicentre, single-arm, phase 2 trialDomenico Russo, Nicola Polverelli, Simona Bernardi, et al.
Leukemia|March 8, 2024
Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE studyAnnalisa Chiappella, Beatrice Casadei, Patrizia Chiusolo, et al.
Haematologica|February 19, 2026
Real-world outcomes in refractory chronic graft-versus-host disease: the Italian multicenter experience with belumosudilFrancesca Bonifazi, Marcello Roberto, Maria Teresa Lupo Stanghellini, et al.
Bone Marrow Transplantation|January 14, 2018
Predicting failure of hematopoietic stem cell mobilization before it starts: the predicted poor mobilizer (pPM) scoreJacopo Olivieri, Immacolata Attolico, Roberta Nuccorini, et al.
Bone Marrow Transplantation|July 2, 2026
Early software-assisted response predicts survival in a prospective cohort of 258 newly diagnosed cGvHD patientsAttilio Olivieri, Giorgia Mancini, Jacopo Olivieri, et al.
Pageof 17